Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies

8Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Previous epidemiological studies have raised the concern that the use of proton pump inhibitors (PPIs) is associated with an increased risk of kidney diseases. To date, no comprehensive meta-analysis has been conducted to assess the association between PPIs and the risk of chronic kidney disease (CKD). Therefore, we conducted a systematic review and meta-analysis to address the association between PPIs and CKD. The primary search was conducted in the most popular databases, such as PubMed, Scopus, and Web of Science. All observational studies evaluated the risk of CKD among PPI users, and non-users were considered for inclusion. Two reviewers conducted data extraction and assessed the risk of bias. Random-effect models were used to calculate pooled effect sizes. A total of 6,829,905 participants from 10 observational studies were included. Compared with non-PPI use, PPI use was significantly associated with an increased risk of CKD (RR 1.72, 95% CI: 1.02–2.87, p = 0.03). This updated meta-analysis showed that PPI was significantly associated with an increased risk of CKD. Association was observed in the same among moderate-quality studies. Until further randomized control trials (RCTs) and biological studies confirm these results, PPI therapy should not stop patients with gastroesophageal reflux disease (GERD). However, caution should be used when prescribing to patients with high-risk kidney disease.

References Powered by Scopus

Meta-analysis of observational studies in epidemiology: A proposal for reporting

17566Citations
N/AReaders
Get full text

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

12741Citations
N/AReaders
Get full text

Chronic kidney disease: Global dimension and perspectives

3187Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Oxalate Homeostasis in Non-Stone-Forming Chronic Kidney Disease: A Review of Key Findings and Perspectives

8Citations
N/AReaders
Get full text

Individualized prevention of proton pump inhibitor related adverse events by risk stratification

5Citations
N/AReaders
Get full text

Comparative efficiency and safety of potassium competitive acid blockers versus Lansoprazole in peptic ulcer: a systematic review and meta-analysis

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wu, C. C., Liao, M. H., Kung, W. M., & Wang, Y. C. (2023). Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies. Journal of Clinical Medicine, 12(6). https://doi.org/10.3390/jcm12062262

Readers' Seniority

Tooltip

Professor / Associate Prof. 2

33%

PhD / Post grad / Masters / Doc 2

33%

Lecturer / Post doc 1

17%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

50%

Pharmacology, Toxicology and Pharmaceut... 1

17%

Nursing and Health Professions 1

17%

Veterinary Science and Veterinary Medic... 1

17%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free